Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Memantine for Borderline Personality Disorder
NCT02097706Phase 2Recruiting
- Sponsor
- Alfred Health
- Start
- Jan 2015
- Primary completion
- Dec 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of memantine in borderline personality disorder (BPD), sponsored by Alfred Health. Started Jan 2015; status: recruiting.
02
Drugs
memantine
03
Conditions
borderline personality disorder (BPD)
Beyond the preview
Go deeper on NCT02097706.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02097706.